Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients

Purpose: Radiotherapy for patients with non-metastatic human epidermal growth factor receptor 2 (HER2) positive breast cancer is commonly administered concurrently with adjuvant trastuzumab. However, there is limited data on the use of concurrent trastuzumab and hypofractionated radiotherapy (Hypo-R...

Full description

Bibliographic Details
Main Authors: Mutlay Sayan, Zeinab Abou Yehia, Apar Gupta, Deborah Toppmeyer, Nisha Ohri, Bruce G. Haffty
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
breast cancer
radiation therapy
hypofractionated breast irradiation
trastuzumab
cardiac toxicity
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00970/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00970/full

Similar Items